Physician profile
James A Delullo
NPI 1861477440
$1,094.51
in general payments reported to CMS, 2019-2025
10 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $77.63 · 2021: $19.05 · 2022: $141 · 2023: $149 · 2024: $268 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $309.68 | 2019-2025 | |
| Stryker Corporation | $249.21 | 2021-2024 | T2 Alpha, Na |
| Smith+Nephew, INC. | $148.42 | 2019-2025 | Grafix Pl |
| Organogenesis INC. | $121.59 | 2023 | Puraply |
| Osteoremedies, LLC | $112.99 | 2024 | Remedy Spectrum Gv Spacer, Biobrush, Remedy Spacer |
| Innovation Technologies INC | $48.70 | 2025 | Irrisept |
| Depuy Synthes Sales INC. | $29.28 | 2022 | |
| Integra Lifesciences Corporation | $27.13 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $26.54 | 2025 | Ethicon, Harmonic, Evarrest |
| Si-Bone, INC. | $20.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Delullo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.